Yuval Rotem is a journalist who writes for Seeking Alpha, focusing on financial analysis and investment insights. With a keen eye for market trends and company performance, Yuval provides in-depth analysis and commentary on various stocks and industries, helping investors make informed decisions.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Yuval Rotem's articles predominantly focus on investment analysis, particularly in the technology and stock market sectors. His coverage often includes data citations, indicating a preference for fact-based insights.
Given this focus, Yuval might be receptive to pitches from financial analysts or industry experts who can offer evidence-backed perspectives on investment opportunities, controversies within companies, or turnaround stories within the technology and stock market sectors.
The themes covered in his articles also include sales & marketing and beauty & fashion topics. Therefore, individuals with expertise in these areas could potentially find an angle to pitch their insights related to consumer behavior trends or industry-specific marketing strategies.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Yuval Rotem
UnitedHealthcare overcomes challenges for long-term success, targets 13-16% earnings growth, presents buying opportunity with $700 price target by 2025.
By: Yuval Rotem
Intuit's Q1'25 misses expectations with increased DOGE-related risks. Find out why INTU stock is a "Sell" amid rising competition and valuation concerns.
By: Yuval Rotem
VICI Properties provides predictable returns but faces limited expansion. Read why VICI stock may benefit from a 7% AFFO yield and treasury yield declines.
By: Yuval Rotem
Salesforce shares surged over 10% post-earnings, driven by excitement around Agentforce. Click here to find out why I rate CRM stock a hold.
By: Yuval Rotem
Universal Music Group experienced an 8.5% decline year-to-date and a nearly 20% drop from its May highs. Find out why I maintain a hold rating on UMGNF stock.
By: Yuval Rotem
Learn why Ferrari's shares declined and why it presents a buying opportunity, plus insights on its market position, brand, and potential growth ahead.
Uber is undervalued, trading at 28 times '25 earnings. Check out why I think Uber shares could more than double by 2025 and what makes it my top pick for 2025.
Financial writer analyzes Adobe's stagnating growth and margin concerns, amidst AI uncertainty and competition, suggesting Adobe as a 'Hold'.
By: Yuval Rotem
CVS Health has struggled post-pandemic due to rising costs, regulatory scrutiny, and poor management decisions, leading to significant underperformance and...
Costco Wholesale Corporation beat Q1 '25 estimates, but next quarter could weaken. Find out why COST stock remains a “Hold” despite high valuation concerns.
(833) 317-6278 
